|
Name |
Cadina-1(10),4-diene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
4,7-dimethyl-1-propan-2-yl-1,2,3,5,6,8a-hexahydronaphthalene
|
|
SMILES |
CC1=CC2C(CCC(=C2CC1)C)C(C)C
|
|
InChI |
InChI=1S/C15H24/c1-10(2)13-8-6-12(4)14-7-5-11(3)9-15(13)14/h9-10,13,15H,5-8H2,1-4H3
|
|
InChIKey |
FUCYIEXQVQJBKY-UHFFFAOYSA-N
|
|
Synonyms |
Cadina-1(10),4-diene; 16729-01-4; 4,7-dimethyl-1-(propan-2-yl)-1,2,3,5,6,8a-hexahydronaphthalene; 1-Isopropyl-4,7-dimethyl-1,2,3,5,6,8a-hexahydronaphthalene; 4,7-dimethyl-1-propan-2-yl-1,2,3,5,6,8a-hexahydronaphthalene; delta-Amorphene; (+)-delta-amorphene; D-Amorphene; Naphthalene, 1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-, (1S-cis)-; cadinene (delta-); 1(10),4-Cadinadiene; DTXSID60862005; DTXSID80274505; CHEBI:140564; FT-0701082; rel-(1R,8aS)-1-isopropyl-4,7-dimethyl-1,2,3,5,6,8a-hexahydronaphthalene
|
|
CAS | 16729-01-4 | |
PubChem CID | 10223 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 3.8 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.518 |
Caco-2 Permeability: | -4.469 | MDCK Permeability: | 0.00001460 |
Pgp-inhibitor: | 0.707 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.927 |
30% Bioavailability (F30%): | 0.456 |
Blood-Brain-Barrier Penetration (BBB): | 0.327 | Plasma Protein Binding (PPB): | 97.30% |
Volume Distribution (VD): | 6.869 | Fu: | 2.34% |
CYP1A2-inhibitor: | 0.321 | CYP1A2-substrate: | 0.591 |
CYP2C19-inhibitor: | 0.374 | CYP2C19-substrate: | 0.916 |
CYP2C9-inhibitor: | 0.554 | CYP2C9-substrate: | 0.785 |
CYP2D6-inhibitor: | 0.018 | CYP2D6-substrate: | 0.19 |
CYP3A4-inhibitor: | 0.355 | CYP3A4-substrate: | 0.497 |
Clearance (CL): | 7.421 | Half-life (T1/2): | 0.051 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.172 |
Drug-inuced Liver Injury (DILI): | 0.741 | AMES Toxicity: | 0.018 |
Rat Oral Acute Toxicity: | 0.062 | Maximum Recommended Daily Dose: | 0.034 |
Skin Sensitization: | 0.037 | Carcinogencity: | 0.229 |
Eye Corrosion: | 0.006 | Eye Irritation: | 0.203 |
Respiratory Toxicity: | 0.021 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001072 | 1.000 | D04CSZ | 0.273 | ||||
ENC002227 | 0.464 | D0P1FO | 0.235 | ||||
ENC000800 | 0.464 | D0O1UZ | 0.224 | ||||
ENC000762 | 0.458 | D04ATM | 0.222 | ||||
ENC000763 | 0.458 | D09PJX | 0.207 | ||||
ENC000831 | 0.439 | D0F2AK | 0.200 | ||||
ENC002224 | 0.439 | D04GJN | 0.198 | ||||
ENC002223 | 0.439 | D0WO8W | 0.197 | ||||
ENC003087 | 0.439 | D01CKY | 0.196 | ||||
ENC002374 | 0.414 | D0K5WS | 0.190 |